Receptor tyrosine-protein kinase erbB-2
CAT No: ta-331
Synonyms/Alias:Receptor tyrosine-protein kinase erbB-2 (369-377)
Receptor tyrosine-protein kinase erbB-2 (369-377) is a synthetic peptide fragment corresponding to amino acids 369 through 377 of the human HER2/neu (erbB-2) protein sequence. As a segment derived from the extracellular domain of the erbB-2 receptor, it serves as a valuable research tool in the study of receptor structure, signaling pathways, and protein-protein interactions. The HER2/neu receptor is a well-characterized member of the epidermal growth factor receptor (EGFR) family, playing a pivotal role in cell growth, differentiation, and signal transduction. Peptides representing specific regions of this receptor, such as the 369-377 fragment, are widely used in biochemical, immunological, and structural studies to elucidate the mechanisms underlying receptor function and regulation.
Epitope mapping: Researchers frequently utilize the 369-377 peptide to identify and characterize linear B-cell or T-cell epitopes within the erbB-2 protein. By incorporating this defined fragment into immunoassays, scientists can assess antibody or cellular immune responses directed against this specific region. Such studies are essential for mapping immunogenic domains, understanding immune recognition of the receptor, and supporting the development of immunological reagents for basic research.
Protein interaction studies: The peptide fragment is employed in binding assays designed to investigate the molecular interactions between the erbB-2 receptor and its ligands, co-receptors, or regulatory proteins. By using this defined sequence, investigators can dissect the contribution of the 369-377 region to overall receptor conformation and its role in mediating specific protein-protein contacts. These insights are valuable for elucidating the structural determinants of receptor activation and downstream signaling.
Peptide-based assay development: The erbB-2 (369-377) peptide serves as a standard or control in a variety of peptide-based analytical platforms, including enzyme-linked immunosorbent assays (ELISA), surface plasmon resonance (SPR), and mass spectrometry. Its well-defined sequence allows for reproducible assay calibration, validation of antibody specificity, and quantitative measurement of peptide-receptor or peptide-antibody interactions. Such applications enhance the precision and reliability of experimental workflows in both basic and translational research settings.
Antibody specificity testing: Laboratories employ this peptide to rigorously evaluate the specificity of monoclonal or polyclonal antibodies raised against the HER2/neu protein. By testing antibody binding to the 369-377 sequence, researchers can confirm epitope recognition, exclude cross-reactivity with unrelated proteins, and select the most suitable reagents for downstream applications such as immunoprecipitation, Western blotting, or immunohistochemistry. This approach supports the development and validation of high-quality immunological tools for receptor analysis.
Structural and functional analysis: The defined sequence of the erbB-2 (369-377) peptide enables detailed structure-function studies aimed at understanding the conformational properties of the receptor's extracellular domain. Through techniques such as circular dichroism, nuclear magnetic resonance (NMR) spectroscopy, or X-ray crystallography, scientists can probe the secondary structure, folding dynamics, and stability of this region. These investigations contribute to a deeper understanding of how specific peptide motifs influence receptor architecture and biological activity, informing the broader field of receptor tyrosine kinase biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.